Keywords: European Commission, Bristol-Myers Squibb, Yervoy, Novo Nordisk, FlexTouch, Melanoma, Pre-filled insulin pens

European Commission and Australia OK Bristol-Myers Yervoy and Novo Nordisk’s FlexTouch

Article | 15 July 2011

Print This

Following a recent positive recommendation from the European Medicine Agency’s advisory panel, Bristol-Myers Squibb today announced that the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in